滇黄精对非酒精性脂肪肝大鼠的保护作用及机制研究

杨兴鑫, 王曦, 董金材, 李凤娇, 毕倩, 顾雯, 俞捷

中国药学杂志 ›› 2018, Vol. 53 ›› Issue (12) : 975-981.

PDF(1966 KB)
PDF(1966 KB)
中国药学杂志 ›› 2018, Vol. 53 ›› Issue (12) : 975-981. DOI: 10.11669/cpj.2018.12.008
·论著·

滇黄精对非酒精性脂肪肝大鼠的保护作用及机制研究

  • 杨兴鑫, 王曦, 董金材, 李凤娇, 毕倩, 顾雯, 俞捷*
作者信息 +

Protective Effects and Mechanisms of Polygonatum kingianum on Nonalcoholic Fatty Liver in Rats

  • YANG Xing-xin, WANG Xi, DONG Jin-cai, LI Feng-jiao, BI Qian, GU Wen, YU Jie*
Author information +
文章历史 +

摘要

目的 探究滇黄精对高脂饮食诱导的非酒精性脂肪肝大鼠的保护作用及其机制。方法 42只SD大鼠随机分为正常对照(生理盐水)组、模型(生理盐水)组、白藜芦醇组(阳性对照,40 mg·kg-1)和滇黄精水提物低、中、高剂量组(1、4、8 g·kg-1),连续灌胃给药14周,每天1次。除正常对照组外其余各组大鼠喂高脂饲料14周诱发非酒精性脂肪肝。于0、6、12、14周眼角取血,检测血清甘油三酯(TG)和总胆固醇(TC)水平;并于14周处死大鼠,测定脏器(肝、脾、肾)指数,检测肝脏中TC、TG、高密度脂蛋白胆固醇(HDL-C)及低密度脂蛋白胆固醇(LDL-C)水平,检测大鼠肝脏线粒体中丙二醛(MDA)、超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-PX)、ATP合酶及呼吸链复合物Ⅰ、Ⅱ水平。结果 高脂饲料喂养大鼠被成功诱发非酒精性脂肪肝。滇黄精水提物各剂量组可显著抑制高脂饮食诱导的大鼠肝脏指数及血清TC升高,减轻肝细胞肿胀、变性、坏死及炎性损伤,抑制肝脏中TC、TG、LDL-C升高及HDL-C降低,抑制肝线粒体中MDA升高及SOD、GSH-PX、ATP合酶与呼吸链复合物Ⅰ、Ⅱ活性降低。结论 滇黄精对高脂饮食诱导的非酒精性脂肪肝大鼠具有保护作用,其机制可能与清除线粒体氧化应激产物MDA,增加线粒体内抗氧化酶SOD 与GSH-PX活性及改善能量代谢障碍有关。

Abstract

OBJECTIVE To investgate the protective effects and mechanisms of Polygonatum kingianum on nonalcoholic fatty liver induced by high-fat diet in rats. METHODS A total of 42 rats were randomly divided into normal control group (normal saline), model group (normal saline), resveratrol group (positive control, 40 mg·kg-1) and low-, middle-and high-dose P. kingianum group (1, 4, 8 g·kg-1). They were intragastrically given corresponding compounds (or normal saline) once a day, lasting for 14 weeks. Nonalcoholic fatty liver was induced by feed with high-fat diet for 14 weeks in those groups except for normal control group. Blood was taken from the corneas at 0, 6, 12 and 14 week, and then the levels of triglyceride (TG) and total cholesterol (TC) in serum were determined. Afterword, the rats were sacrificed at 14 week followed by the measurement of organs indices of liver、spleen and kidney, as well as the detection of levels of TC, TG, high density lipoprotein cholesterol (HDL-C) and low density lipoprotein cholesterol (LDL-C) in liver tissues. Furthermore, the levels of malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-PX), ATP synthase and respiratory chain complex Ⅰ and Ⅱ in hepatic mitochondria were determined. RESULTS Nonalcoholic fatty liver was successfully induced by high-fat diet in rats. The different doses of water extract of P. kingianum could significantly inhibit the increasing of liver index and serum TC in high-fat diet-induced rats, alleviate swelling, degeneration, necrosis and inflammatory injury of hepatic cells, inhibit the increasing of TC, TG and LDL-C and decrease of HDL-C in liver tissues, as well as inhibit the exaltation of MDA level and reduction of SOD, GSH-PX, ATP synthase and respiratory chain complex Ⅰ and Ⅱ activity in hepatic mitochondria. CONCLUSION P. kingianum shows protective effects on high-fat diet-induced nonalcoholic fatty liver in rats. The action mechanism may be related to the elimination of oxidative stress product (MDA) and improvement of antioxidant enzyme activity (SOD and GSH-PX) in hepatic mitochondria, as well as the improvement of energy metabolism obstacle.

关键词

滇黄精 / 非酒精性脂肪肝 / 保护作用 / 氧化应激 / 线粒体 / 能量代谢

Key words

Polygonatum kingianum / nonalcoholic fatty liver / protective effect / oxidative stress / mitochondria / energy metabolism

引用本文

导出引用
杨兴鑫, 王曦, 董金材, 李凤娇, 毕倩, 顾雯, 俞捷. 滇黄精对非酒精性脂肪肝大鼠的保护作用及机制研究[J]. 中国药学杂志, 2018, 53(12): 975-981 https://doi.org/10.11669/cpj.2018.12.008
YANG Xing-xin, WANG Xi, DONG Jin-cai, LI Feng-jiao, BI Qian, GU Wen, YU Jie. Protective Effects and Mechanisms of Polygonatum kingianum on Nonalcoholic Fatty Liver in Rats[J]. Chinese Pharmaceutical Journal, 2018, 53(12): 975-981 https://doi.org/10.11669/cpj.2018.12.008
中图分类号: R965   

参考文献


[1] BEDOGNI G, MIGLIOLI L, MASUTTI F, et al. Prevalence of and risk factors for nonalcoholic fatty liver disease:the dionysos nutrition and liver study[J]. Hepatology, 2005, 42(1):44-52.
[2] Ch.P (2015). Vol Ⅰ(中国药典2015年版. 一部) [S]. 2015:175-177.
[3] SUN Z. Resource research of three species of Polygonatum Mill. and quality evaluation of Polygonatum cirrhifolium (Wall.) Roylel[D]. Beijing:Beijing University of Chinese Medicine, 2009.
[4] CHEN H, FENG S S, SUN Y J, et al. Advances in studies on chemical constituents of three medicinal plants from Polygonatum Mill. and their pharmacological activities[J]. Chin Tradit Herb Drug (中草药), 2015, 46(15):2329-2338.
[5] LIU X Q, YI H, YAO L, et al. Advances in plants of and discussion of its development prospects[J]. Chin Pharm J (中国药学杂志), 2017, 52(7):530-534.
[6] LI W, PENG R, TANG L B, et al. The effects and mechanism of Polygonatum on rat′s cerebral ischemia treatment[J]. J Dali Univ (大理学院学报), 2006,5(10):19-21.
[7] LU J M, YAN H L, WANG Y F, et al. Inhibitory effect of Polygonatum kingianum Rhizoma and its active ingredient groups on α-glucosidase[J]. Mod Chin Med(中国现代中药), 2015, 17(3):200-203.
[8] LU J M, WANG Y F, YAN H L, et al. Antidiabetic effect of total saponins from Polygonatum kingianum in streptozotocin-induced daibetic rats[J]. J Ethnopharmacol, 2016, 179:291-300.
[9] YAN H, LU J, WANG Y, et al. Intake of total saponins and polysaccharides from Polygonatum kingianum affects the gut microbiota in diabetic rats[J]. Phytomedicine, 2017, 26:45-54.
[10] POULSEN M M, LARSEN J Ø, HAMILTON-DUTOIT S, et al. Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet[J]. Nutr Res, 2012, 32(9):701-708.
[11] FERRAMOSCA A, DI GIACOMO M, ZARA V. Antioxidant dietary approach in treatment of fatty liver:new insights and updates[J]. World J Gastroenterol, 2017, 23(23):4146-4157.
[12] WU R. Therapeutical effect of resveratrol on the nonalcoholic fatty liver disease rat model and its potential mechanism [D]. Hefei:Anhui Medical University, 2016.
[13] REN P, WANG W B, OUYANG H C, et al. Effects of resveratrol on the lipid peroxidation of hepatic tissues from nonalcoholic fatty liver disease mice[J]. Lishizhen Med Mater Med Res (时珍国医国药), 2011, 22(9):2149-2151.
[14] LAMBERT J E,RAMOS-ROMAN M A,BROWNING J D,et al. Increased denovo lipogenesis is a distinct characteristic of individuals with non-alcoholic fatty liver disease[J]. Gastroenterology, 2014, 146(3):726-735.
[15] SANYAL A J, CAMPBELL-SARGENT C, MIRSHAHI F, et al. Nonalcoholic steatohepatitis:association of insulin resistance and mitochondrial abnormalities[J]. Gastroenterology, 2001, 120(5):1183-1192.
[16] GU L X. The effects of Zhifanggan on mitochondria of experimental NAFLD rats [D]. Guangzhou:Guangzhou University Chinese Medicine, 2010.
[17] ZHANG W, XIE X S, YU S, et al. Effect of Wuweibaoganwan on rat models of acute hepatic damage[J]. Med J Qilu (齐鲁医学杂志), 2011, 26(3):219-224.
[18] ZHANG D H, CHENG H, XIONG Y, et al. Protective effect of isoliquiritigen in against acute chemical hepatic injury in rats[J]. Chin Hosp Pharm J (中国医院药学杂志), 2008, 28(7):511-514.
[19] SONG J, ZHAO J N, WANG X D, et al. Protective effects of Shaoganduogan on hepatocyte mitochondria in subacute liver injury rat induced by carbon tetrachloride[J]. China J Chin Mater Med (中国中药杂志), 2011, 36(7):931-937.
[20] QIU X Z, CHEN Y, ZHOU M. The defense system of mitochondrial oxidative stress injury[J]. Chem Life (生命的化学), 2001, 21(2):141-143.
[21] FAN L L, CHEN D F. Effect of structural and functional damages in hepatic mitochondria on genesis of NAFLD[J]. Chongqing Med (重庆医学), 2007, 36(15):1503-1505.
[22] TIAN H, HAO R, ZHAO G L, et al. Pharmacological effects of white radish extract on nonalcoholic fatty liver in rats[J]. Food Sci (食品科学), 2011, 32(7):300-304.
[23] ZHANG R, LI X B, XU D Z, et al. Effect of yellow leaves on the content of ATP and ADP in liver tissue of nonalcoholic fatty liver in rats[J]. Pharmacol Clin Chin Mater Med (中药药理与临床), 2012, 28(2):95-98.

基金

国家自然科学基金项目资助(81660596,81460623,81760733);云南省应用基础研究计划项目资助(2017FF117-(013),2016FD050);云南省刘昌孝院士工作站资助;云南省中青年学术和技术带头人后备人才项目资助(2015HB053);云南省高校南药研究协同创新中心项目资助(30270100500)
PDF(1966 KB)

Accesses

Citation

Detail

段落导航
相关文章

/